학술논문
Neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel plus trastuzumab and pertuzumab followed by epirubicin and cyclophosphamide for operable HER2-positive primary breast cancer: a multicenter phase II clinical trial (PerSeUS-BC04)
Document Type
Article
Author
Source
In: Breast Cancer . (Breast Cancer, March 2023, 30(2):293-301)
Subject
Language
English
ISSN
18804233
13406868
13406868